EUVIMEDEUVIMED entdecken
Fallbericht

Treatment of Refractory Pruritic Dermatitis in the Setting of Primary Biliary Cholangitis and CREST Syndrome With Upadacitinib

Albert E Zhou, Sowmya Ravi, Michael Murphy, Jun Lu, Katalin Ferenczi

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.9129 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Albert E Zhou und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: CREST Syndrome, Dermatitis, Heterocyclic Compounds, 3-Ring, Janus Kinase Inhibitors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CREST SyndromeDermatitisHeterocyclic Compounds, 3-RingJanus Kinase InhibitorsLiver Cirrhosis, BiliaryPruritusFemaleHumansTreatment OutcomeAged

Substanzen

Heterocyclic Compounds, 3-RingJanus Kinase Inhibitorsupadacitinib

Zitieren

APA

Zhou, A. E., Ravi, S., Murphy, M., Lu, J., & Ferenczi, K. (2025). Treatment of Refractory Pruritic Dermatitis in the Setting of Primary Biliary Cholangitis and CREST Syndrome With Upadacitinib. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9129

Vancouver

Zhou AE, Ravi S, Murphy M, Lu J, Ferenczi K. Treatment of Refractory Pruritic Dermatitis in the Setting of Primary Biliary Cholangitis and CREST Syndrome With Upadacitinib. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9129

BibTeX
@article{Zhou2025,
  author = {Zhou, Albert E and Ravi, Sowmya and Murphy, Michael and Lu, Jun and Ferenczi, Katalin},
  title = {Treatment of Refractory Pruritic Dermatitis in the Setting of Primary Biliary Cholangitis and CREST Syndrome With Upadacitinib},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.9129}
}
Kostenlos starten →